XBiotech Inc. (XBIT): Capital Expenditures
$289.0K
Year ended 2025-12-31
$144.0K
Trailing 12 months to 2026-06-30
-20.9%
3-year compound annual growth
-40.0%
5-year compound annual growth
-18.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $289.0K | -77.8% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $1.30M | +260.2% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $362.0K | -38.1% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | $585.0K | -83.4% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $3.52M | -5.4% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $3.73M | n/m | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $204.0K | +67.2% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $122.0K | -91.3% | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $1.41M | -70.4% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $4.75M | +104.4% | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | $2.32M | +66.2% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $1.40M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $59.0K | n/a | 2016-04-15, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| XBiotech Inc. (XBIT) | 2025-12-31 | $289.0K | -77.8% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $552.0K | -66.6% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $0 | -100.0% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $220.0K | -29.0% |
| Veradermics, Inc (MANE) | 2025-12-31 | $24.0K | n/a |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $91.0K | -82.3% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $518.0K | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | $2.00M | -76.8% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $546.0K | -78.5% |
Compare XBIT, WHWK, OVID, CTMX side by side · Screen every company in Pharmaceutical Preparations ↗